Healthcare -
Biotechnology - NASDAQ - US
$ 37.35
2.38 %
$ 3.46 B
Market Cap
-10.09
P/E
Price Target
Average
93.54%
Revenue Forecast
Estimate
405.72%
EBIT
Estimate
--32.60%
Net Income
Estimate
48.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Crinetics Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CRNX of $72.3 , with forecasts ranging from
a
low of
$54 to a high of $97 .
CRNX Lowest Price Target
Wall Street Target
54 USD
44.58%
CRNX Average Price Target
Wall Street Target
72.3 USD
93.54%
CRNX Highest Price Target
Wall Street Target
97 USD
159.71%
REVENUE FORECAST
Revenue Forecast Chart CRNX
EBIT FORECAST
EBIT Forecast Chart CRNX
NET INCOME FORECAST
Net Income Chart CRNX